• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTERVASCULAR SAS INTERGARD/HEMAGARD; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTERVASCULAR SAS INTERGARD/HEMAGARD; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER Back to Search Results
Model Number IGK0008RS45 - INTERGARD KNITTED RS
Device Problem Manufacturing, Packaging or Shipping Problem (2975)
Patient Problem Blood Loss (2597)
Event Date 10/02/2019
Event Type  Injury  
Manufacturer Narrative
Trackwise id # (b)(4).The investigation is still ongoing.A follow-up report will be sent upon completion of the investigation.
 
Event Description
According to the reporter: "use interguard on the right a-f bypass.A large amount of blood leaked from the graft after passing through the artificial blood vessel using a sheath type tunneler and releasing the graft after the central anastomosis was terminated and flowing the blood.Blood leakage seemed to ooze from the entire graft, not from the anastomosis, but the amount of bleeding was large and the location could not be specified.If i could not proceed with the procedure and looked at the situation for a while, the blood leak had subsided and the operation continued.After that, the operation was completed without any problems, but there is an opinion that postoperative edema is a concern.This time, the left a-f bypass was also anastomosed with another interguard, but there was no problem with this, so the institution determined that it was not due to the patient's influence.".
 
Event Description
See initial mdr mfr report # 1640201-2019-00081.
 
Manufacturer Narrative
Corrected data: blocks d8, d10 , h3 and h6 are corrected.Block d8 was checked as "yes" inadvertently.Block d10 was checked as ¿no¿ because the product was not known as available at the date of the initial report but it was finally returned to the manufacturer.Block h3 was checked as ¿no¿ because the product was not known as available at the date of the initial report but it was finally returned to the manufacturer.Block h6 mentioned 4117 as method code but it is now changed with 10 as the product is now available and sent to an external and independent laboratory for examination.Additional manufacturer narrative: (11/213) one retention sample from same lot and coated on the same day and under the same conditions as the involved device was underwent water permeability testing.The test result indicated a value well within product specifications (< 5 ml/cm²/min).(10/3233) the involved device was sent to an external and independent laboratory for examination.The investigation is ongoing.(11) the investigation is still ongoing.A follow-up report will be sent upon completion of the investigation.
 
Manufacturer Narrative
Additional mfg narrative: the case has been reviewed by our corporate medical officer, his assessment is as follows: "the event recorded describes the use of an intergard knitted graft to perform an axillary to femoral artery bypass.The surgeon mentioned significant oozing from the graft after de-clamping following the axillary anastomosis.The bleeding was homogenously distributed across the graft.After few minutes, the oozing stopped and the procedure was completed successfully.The analysis of the specimen received was inconclusive.The hypothesis is that the collagen coating was disrupted by tunneling the graft.This action is necessary and it could require significant force that is transmitted to the graft.In this case, the graft was anastomosed to another intergard product that did not show the same behavior therefore it is assumed that patient's preconditions and coagulation factors did not play a role in the event.No additional information has been provided regarding the patient's recovery." (67) the conducted investigation would tend to indicate that the product was not defective at the time of manufacturing.Please note that, as per instruction for use, care should be taken when handling the graft to avoid damaging the collagen coating.
 
Event Description
See initial mfr report # 1640201-2019-00081.Complaint # (b)(4).
 
Event Description
See initial mfr report # 1640201-2019-00081.Complaint # (b)(4).
 
Manufacturer Narrative
(10/213) the involved device was sent to an external and independent laboratory for examination.Their conclusion are as follows : "this segment probably corresponds to a residual segment of the implanted graft, no macroscopical defects in the textile structure were observed which could explain the excessive permeability noticed during the implantation.Since the segment is completely impregnated with blood the initial permeability of the graft cannot be verified.(11) the investigation is still ongoing.A follow-up report will be sent upon completion of the investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTERGARD/HEMAGARD
Type of Device
PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER
Manufacturer (Section D)
INTERVASCULAR SAS
zone industrielle athelia i
la ciotat
MDR Report Key9249566
MDR Text Key168281435
Report Number2242352-2019-01201
Device Sequence Number1
Product Code DSY
UDI-Device Identifier00384401000778
UDI-Public00384401000778
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Type of Report Initial,Followup,Followup,Followup
Report Date 05/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/29/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2023
Device Model NumberIGK0008RS45 - INTERGARD KNITTED RS
Device Catalogue NumberIGK0008RS45
Device Lot Number18M27
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA05/20/2020
Distributor Facility Aware Date04/28/2020
Event Location Hospital
Date Report to Manufacturer05/20/2020
Date Manufacturer Received04/28/2020
Is This a Reprocessed and Reused Single-Use Device? Yes
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
-
-